The diagnosis, staging, and treatment options for mycosis fungoides (Q36771218)

16 August 2017

1 reference

title

The diagnosis, staging, and treatment options for mycosis fungoides (English)

1 reference

16 August 2017

Connie A Keehn

1

1 reference

16 August 2017

Iriana P Belongie

2

1 reference

16 August 2017

Galina Shistik

3

1 reference

16 August 2017

Neil A Fenske

4

1 reference

16 August 2017

L Frank Glass

5

1 reference

16 August 2017

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

14

1 reference

16 August 2017

2

1 reference

16 August 2017

102-111

1 reference

WHO-EORTC classification for cutaneous lymphomas

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Mycosis fungoides and sezary syndrome: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

On the diagnosis of erythrodermic cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Mycosis fungoides in relation to environmental exposures and immune response: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Cutaneous T-cell lymphoma and human immunodeficiency virus infection: 2 cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Identification of herpes simplex virus DNA and lack of human herpesvirus-8 DNA in mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Lung involvement in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

The pathogenesis of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Cutaneous T-cell lymphoma and human immunodeficiency virus. The spectrum broadens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

D'emblee type of mycosis fungoides of head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Follicular mycosis fungoides. A histopathologic analysis of nine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Folliculotropic mycosis fungoides with central nervous system involvement: demonstration of tumor clonality in intrafollicular T cells using laser capture microdissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Ketron-Goodman disease, Woringer-Kolopp disease, and pagetoid reticulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Granulomatous slack skin. Report of three patients with an updated review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Granulomatous slack skin: treatment with extensive surgery and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Circulating Sezary cells in hospitalized dermatology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Sézary syndrome: diagnosis, prognosis, and critical review of treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Topical carmustine (BCNU) in the treatment of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Total skin electron beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Interferons in the treatment of skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Optimizing bexarotene therapy for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Standard and experimental therapy in cutaneous T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480701400203

10.1177/107327480701400203

21 January 2018

Identifiers

DOI

0 references

1 reference